PLASMA-LEVELS OF FIBRONECTIN AND PROSTACYCLIN METABOLITE IN PERIPARTUM PREECLAMPTIC WOMEN

被引：12

作者：

CALVIN, S

WEINSTEIN, L

WITTE, MH

FINLEY, PR

机构：

[1] Departments of Obstetrics and Gynecology, Surgery, and Pathology, University Medical Center, Tucson, Arizona

来源：

AMERICAN JOURNAL OF PERINATOLOGY | 1990年 / 7卷 / 02期

关键词：

D O I：

10.1055/s-2007-999462

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Plasma fibronectin and prostacyclin levels have been reported to vary in preeclamp-tic women when compared with pregnant control women. Elevation of fibronectin and deficiency of prostacyclin have been postulated to be due to endothelial cell disruption or dysfunction. Eighteen preeclamptic women and 19 normal pregnant controls were evaluated for plasma levels of fibronectin and the prostacyclin metabolite 6-keto-prosta-glandin F1° (6-keto-PGF1°). 6-keto-PGF1° and fibronectin plasma levels in patients were significantly different from control patients, with preeclamptic patients exceeding control subjects. Five patients had serial samples of 6-keto-PGF1° prior to, during, and after intravenous magnesium sulfate therapy and no consistent effect was noted. No correlation existed between fibronectin and 6-keto-PGF1° levels or between either compound and platelet count or liver function tests. Despite an overall elevation of fibronectin in preeclamptic patients, two patients with the hemolysis, elevated liver tests, and low platelet count syndrome showed low normal fibronectin levels coinciding with throm-bocytopenia, hemolysis, and liver dysfunction. The magnitude of fibronectin elevation may therefore not predict the severity of preeclampsia. The significance of these findings is discussed. © 1990, by Thieme Medical Publishers, Inc. All rights reserved.

引用

页码：125 / 129

页数：5

共 11 条

[1] Lazarchick J., Stubbs T.M., Romein L., Van Dorsten J.P., Loadholt C.B., Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic, Am J Obstet Gynecol, 154, pp. 1050-1052, (1986)
[2] Hamberg M., Tuvemo T., Svensson J., Jonsson C.E., Formation and action of prostacyclin in the isolated human umbilical artery, Acta Physiol Scand, 106, pp. 289-292, (1979)
[3] Walsh S.W., Behr M.J., Allen N.H., Placental prostacyclin production in normal and toxemic pregnancies, Am J Obstet Gynecol, 151, pp. 110-115, (1985)
[4] Yamaguchi M., Mori N., 6-Keto prostacyclin Fltx, thromboxane B 2, and 13, 14-dihydro-15-keto prostaglandin F concentrations of normotensive and preeclamptic patients during pregnancy, delivery, and the postpartum period, Am J Obstet Gynecol, 151, pp. 121-127, (1985)
[5] Koullapis E.N., Nicolaides K.H., Collins W.P., Rodeck C.H., Campbell S., Plasma prostanoids in pregnancy-induced hypertension, Br J Obstet Gynaecol, 89, pp. 617-621, (1982)
[6] Jouppila P., Kirkinen P., Koivula A., Ylikorkala O., Failure of exogenous prostacyclin to change placental and fetal blood flow in preeclampsia, Am J Obstet Gynecol, 151, pp. 661-665, (1985)
[7] Watson K., Moldow C., Ogburn P., Jacob H., Magnesium sulfate: Rationale for its use in preeclampsia, Proc Natl Acad Sci USA, 83, pp. 1075-1078, (1986)
[8] Management of preeclampsia, American College of Obstetricians and Gynecologists Technical Bulletin 91, (1986)
[9] Hess L.W., O'Brien W.F., Holmberg J.A., Winkel C.A., Monaghan W.P., Hemming V.G., Plasma and amniotic fluid concentrations of fibronectin during normal pregnancy, Obstet Gynecol, 68, pp. 25-82, (1986)
[10] Saleh A.A., Bottoms S.F., Welch R.A., Ali A.M., Mariona F.G., Mammen E.F., Preeclampsia, delivery, and the hemostatic system, Am J Obstet Gynecol, 157, pp. 331-336, (1987)

← 1 2 →